Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
66.82
-1.27 (-1.87%)
At close: Sep 4, 2026, 4:00 PM EDT
67.00
+0.18 (0.27%)
After-hours: Sep 4, 2026, 7:56 PM EDT
BMY Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 136,494 | 109,809 | 114,714 | 104,403 | 159,703 | 138,395 | |
Market Cap Growth | 41.18% | -4.28% | 9.88% | -34.63% | 15.40% | -1.27% |
Enterprise Value | 170,083 | 143,990 | 157,791 | 135,780 | 190,911 | 168,441 |
Last Close Price | 66.82 | 52.18 | 52.12 | 45.01 | 60.94 | 51.22 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.71 | 15.57 | - | 13.01 | 25.24 | 19.79 |
Forward PE | 10.41 | 8.73 | 7.96 | 6.85 | 9.26 | 8.00 |
PS Ratio | 2.78 | 2.28 | 2.38 | 2.32 | 3.46 | 2.98 |
PB Ratio | 6.12 | 5.93 | 7.00 | 3.54 | 5.13 | 3.84 |
P/FCF Ratio | 11.93 | 8.55 | 8.23 | 8.25 | 13.37 | 9.09 |
P/OCF Ratio | 10.68 | 7.76 | 7.55 | 7.53 | 12.22 | 8.54 |
PEG Ratio | - | 0.10 | 10.92 | 16.44 | 3.55 | 2.31 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.46 | 2.99 | 3.27 | 3.02 | 4.14 | 3.63 |
EV/EBITDA Ratio | 8.98 | 7.53 | 8.13 | 7.49 | 9.83 | 8.71 |
EV/EBIT Ratio | 10.88 | 9.57 | 16.05 | 16.23 | 20.89 | 19.65 |
EV/FCF Ratio | 14.87 | 11.21 | 11.32 | 10.73 | 15.98 | 11.06 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 2.02 | 2.55 | 3.13 | 1.41 | 1.31 | 1.27 |
Debt / EBITDA Ratio | 2.34 | 2.43 | 2.59 | 2.24 | 2.07 | 2.33 |
Debt / FCF Ratio | 3.94 | 3.67 | 3.68 | 3.28 | 3.42 | 2.99 |
Net Debt / Equity Ratio | 1.51 | 1.95 | 2.44 | 0.98 | 1.01 | 0.79 |
Net Debt / EBITDA Ratio | 1.77 | 1.89 | 2.06 | 1.59 | 1.63 | 1.47 |
Net Debt / FCF Ratio | 2.94 | 2.81 | 2.87 | 2.28 | 2.64 | 1.86 |
Asset Turnover | 0.54 | 0.53 | 0.51 | 0.47 | 0.45 | 0.41 |
Inventory Turnover | 5.09 | 5.03 | 4.58 | 4.25 | 4.57 | 4.77 |
Quick Ratio | 1.29 | 1.08 | 1.06 | 1.24 | 1.06 | 1.36 |
Current Ratio | 1.53 | 1.25 | 1.25 | 1.43 | 1.25 | 1.52 |
Return on Equity (ROE) | 46.60% | 40.44% | -38.95% | 26.53% | 18.91% | 18.98% |
Return on Assets (ROA) | 10.72% | 10.29% | 6.55% | 5.45% | 5.54% | 4.70% |
Return on Invested Capital (ROIC) | 21.68% | 20.35% | 17.03% | 13.13% | 11.84% | 10.80% |
Return on Capital Employed (ROCE) | 22.70% | 22.60% | 14.30% | 11.50% | 12.20% | 9.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.80% | 6.42% | -7.80% | 7.69% | 3.96% | 5.05% |
FCF Yield | 8.38% | 11.70% | 12.15% | 12.12% | 7.48% | 11.01% |
Dividend Yield | 3.77% | 4.77% | 4.64% | 5.13% | 3.59% | 3.92% |
Payout Ratio | 55.47% | 71.52% | - | 59.11% | 73.24% | 62.85% |
Buyback Yield / Dilution | -0.47% | -0.59% | 2.45% | 3.17% | 4.41% | 0.58% |
Total Shareholder Return | 3.30% | 4.18% | 7.10% | 8.30% | 8.00% | 4.50% |